Results 171 to 180 of about 15,262 (192)

Influenza A Infection Triggers Thrombotic Thrombocytopenic Purpura by Producing the Anti-ADAMTS13 IgG Inhibitor

, 2010
Nobuharu Kosugi, Yuya Tsurutani, Ayami Isonishi, Yuji Hori, Masanori Matsumoto, Yoshihiro Fujimura   +5 more
openalex   +2 more sources

An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: methodology [PDF]

, 2013
Ardissino, Gianluigi, Ariceta, Gema, Beauchamp, Jon, Cohen, David, Fremeaux-Bacchi, Veronique, Greenbaum, Larry A, Johnson, Sally, Licht, Christoph, Ogawa, Massayo, Schaefer, Franz, Vande Walle, Johan   +10 more
core  

The effects of coagulation factors on the risk of lung cancer: a Mendelian randomization study. [PDF]

Discov Oncol
Zhou H, Mao X, Guo J, Yang X, Huang T.
europepmc   +1 more source

A Comparative Analysis of the Roles of von Willebrand Factor and ADAMTS13 in Hepatocellular Carcinoma: A Bioinformatics and Microarray-Based Study. [PDF]

Curr Issues Mol Biol
Ayan D, Bozkurt Polat ŞB, Bayram E, Özmen E, Aydın FE, Ersan S.   +5 more
europepmc   +1 more source

PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database. [PDF]

BMC Nephrol
Uriol-Rivera MG, Ernst FR, Booth JN, Comas À, Gasteyger C, Tomazos I, Lum C, Wang Y, Ávila AI.   +8 more
europepmc   +1 more source

Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology. [PDF]

Am J Clin Pathol
Jacobs JW, Stuart MS, Tange JI, Leger RR, Ashrani AA, Chen D, Pruthi RK, Sridharan M, Seheult JN.   +8 more
europepmc   +1 more source

Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS. [PDF]

Blood Adv
Bonnez Q, Legan ER, Pareyn I, Boudry F, Anckaert J, Tersteeg C, De Meyer SF, Li R, Vanhoorelbeke K.   +8 more
europepmc   +1 more source

Prospective Study of ADAMTS13 and von Willebrand Factor's Role in the Prediction of Outcomes in Acute Ischemic Stroke. [PDF]

J Clin Med
Makris M, Gavriilaki E, Ztriva E, Evangelidis P, Lefkou E, Vlachaki E, Bountola S, Perifanis V, Matsagkas M, Savopoulos C, Kaiafa G.   +10 more
europepmc   +1 more source

Agents of shield: glycans mask antibody epitopes on ADAMTS13. [PDF]

Blood Adv
Kretz CA.
europepmc   +1 more source

Thrombotic Thrombocytopenic Purpura: Overview on the Last 10 Years of Plasma Exchange Treatment in Hospital São José, Lisbon [PDF]

, 2011
Gutierrez, AS, Tavares, M
core